Misoprostol for preventing and treating postpartum hemorrhage in the community: A closer look at the evidence

International Journal of Gynecology and Obstetrics

Volumn 119, Issue 2, 2012, Pages 105-110

  Oladapo, Olufemi T ^a  

^a OLABISI ONABANJO UNIVERSITY   (Nigeria)

Author keywords

Community; Misoprostol; Postpartum hemorrhage; Prevention; Treatment

Indexed keywords

MISOPROSTOL; OXYTOCIN; PLACEBO;

ARTICLE; CAREGIVER; CHILDBIRTH; COMMUNITY CARE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; MEDICAL RESEARCH; MORBIDITY; POSTPARTUM HEMORRHAGE; PRENATAL CARE; PRIORITY JOURNAL; TREATMENT OUTCOME; UTEROTONICS;

EID: 84866738741     PISSN: 00207292     EISSN: 18793479     Source Type: Journal    
DOI: 10.1016/j.ijgo.2012.08.004     Document Type: Article

References (26)

1. International Confederation of Midwives, International Federation of Gynecology and Obstetrics Prevention and Treatment of Postpartum Haemorrhage: New Advances for Low Resource Settings. Joint Statement Int J Gynecol Obstet 97 2 2007 160 163
2. World Health Organization WHO Recommendations for the Prevention of Postpartum Haemorrhage 2007 WHO Geneva Available at: http://whqlibdoc.who.int/ hq/2007/WHO-MPS-07.06-eng.pdf
3. World Health Organization WHO Model Lists of Essential Medicines 17th edition March 2011 Available at: http://www.who.int/medicines/publications/ essentialmedicines/en/
4. A. Starrs, and B. Winikoff Misoprostol for postpartum hemorrhage: moving from evidence to practice Int J Gynecol Obstet 116 1 2011 1 3
5. S. Rajbhandari, S. Hodgins, H. Sanghvi, R. McPherson, Y.V. Pradhan, and A.H. Baqui Expanding uterotonic protection following childbirth through community-based distribution of misoprostol: operations research study in Nepal Int J Gynecol Obstet 108 3 2010 282 288
6. H. Sanghvi, N. Ansari, N.J. Prata, H. Gibson, A.T. Ehsan, and J.M. Smith Prevention of postpartum hemorrhage at home birth in Afghanistan Int J Gynecol Obstet 108 3 2010 276 281
7. M. Potts, N. Prata, and N.N. Sahin-Hodoglugil Maternal mortality: one death every 7 min Lancet 375 9728 2010 1762 1763
8. World Health Organization Clarifying WHO position on misoprostol use in the community to reduce maternal death 2010 WHO Geneva Available at: http://whqlibdoc.who.int/hq/2010/WHO-RHR-10.11-eng.pdf
9. A.M. Gülmezoglu, M. Mathai, J.P. Souza, C. d'Arcangues, and M. Mbizvo Misoprostol use in the community to reduce maternal death Lancet 376 9745 2010 955
10. G.J. Hofmeyr, V.C. Nikodem, M. de Jager, and B.R. Gelbart A randomised placebo controlled trial of oral misoprostol in the third stage of labour Br J Obstet Gynecol 105 9 1998 971 975 (Pubitemid 28442322)
11. G.J. Hofmeyr, V.C. Nikodem, M. de Jager, A. Drakely, and B. Gelbart Oral misoprostol for labour third stage management: randomised assessment of side-effects (Part 2) Proceedings of the 17th Conference on Priorities in Perinatal Care 1998 53 54 South Africa
12. G.J. Hofmeyr, V.C. Nikodem, M. de Jager, and A. Drakely Side-effects of oral misoprostol in the third stage of labour - a randomised placebo-controlled trial S Afr Med J 91 5 2001 432 435
13. A.A. Bamigboye, G.J. Hofmeyr, and D.A. Merrell Rectal misoprostol in the prevention of postpartum hemorrhage: a placebo-controlled trial Am J Obstet Gynecol 179 4 1998 1043 1046 (Pubitemid 28489305)
14. D.V. Surbek, P.M. Fehr, I. Hosli, and W. Holzgreve Oral misoprostol for third stage of labor: a randomized placebo-controlled trial Obstet Gynecol 94 2 1999 255 258 (Pubitemid 29352872)
15. M. Benchimol, J. Gondry, J.E. Mention, O. Gagneur, and J.C. Boulanger Role of misoprostol in the delivery outcome [in French] J Gynecol Obstet Biol Reprod (Paris) 30 6 2001 576 583
16. L. Hoj, P. Cardoso, B.B. Nielsen, L. Hvidman, J. Nielsen, and P. Aaby Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomized double blind clinical trial BMJ 331 7519 2005 723
17. R.J. Derman, B.S. Kodkany, S.S. Goudar, S.E. Geller, V.A. Naik, and M.B. Bellad Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomized controlled trial Lancet 368 9543 2006 1248 1253 (Pubitemid 44485797)
18. N. Mobeen, J. Durocher, N.F. Zuberi, N. Jahan, J. Blum, and S. Wasim Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial BJOG 118 3 2011 353 361
19. G.J. Hofmeyr, A.M. Gülmezoglu, N. Novikova, V. Linder, S. Ferreira, and G. Piaggio Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects Bull World Health Organ 87 9 2009 666 677
20. H.A. Mousa, and Z. Alfirevic Treatment for primary postpartum haemorrhage Cochrane Database Syst Rev 1 2007 CD003249
21. B. Winikoff, R. Dabash, J. Durocher, E. Darwish, T.N. Nguyen, and W. León Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial Lancet 375 9710 2010 210 216
22. O. Tunçalp, G.J. Hofmeyr, and A.M. Gulmezoglu Prostaglandins for preventing postpartum haemorrhage Cochrane Database Syst Rev 3 2007 CD000494 [Update: In Press]
23. S. Lewin, S. Munabi-Babigumira, C. Glenton, K. Daniels, X. Bosch-Capblanch, and B.E. van Wyk Lay health workers in primary and community health care for maternal and child health and the management of infectious diseases Cochrane Database Syst Rev 3 2010 CD004015
24. G. Walraven, J. Blum, Y. Dampha, M. Sowe, L. Morison, and B. Winikoff Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia; a randomised controlled trial BJOG 112 9 2005 1277 1283 (Pubitemid 43960926)
25. N. Prata, G. Mbaruku, M. Campbell, M. Potts, and F. Vahidnia Controlling postpartum hemorrhage after homebirths in Tanzania Int J Gynecol Obstet 90 1 2005 51 55 (Pubitemid 40909958)
26. O.T. Oladapo, B. Fawole, J. Blum, and E. Abalos Advance misoprostol distribution for preventing and treating postpartum haemorrhage Cochrane Database Syst Rev 2 2012 CD009336